Cover Image

Microbiota-based markers predictive of development of Clostridioides difficile infection

Antibiotic-induced modulation of the intestinal microbiota can lead to Clostridioides difficile infection (CDI), which is associated with considerable morbidity, mortality, and healthcare-costs globally. Therefore, identification of markers predictive of CDI could substantially contribute to guiding...

Full description

Saved in:
Bibliographic Details
Main Authors: Berkell, Matilda (Author) , Mysara, Mohamed (Author) , Xavier, Basil Britto (Author) , van Werkhoven, Cornelis H. (Author) , Monsieurs, Pieter (Author) , Lammens, Christine (Author) , Ducher, Annie (Author) , Vehreschild, Maria J. G. T. (Author) , Goossens, Herman (Author) , de Gunzburg, Jean (Author) , Bonten, Marc J. M. (Author) , Malhotra-Kumar, Surbhi (Author) , Merle, Uta (Author)
Format: Article (Journal)
Language:English
Published: 14 April 2021
In: Nature Communications
Year: 2021, Volume: 12, Pages: 1-14
ISSN:2041-1723
DOI:10.1038/s41467-021-22302-0
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/s41467-021-22302-0
Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/s41467-021-22302-0
Get full text
Author Notes:Matilda Berkell, Mohamed Mysara, Basil Britto Xavier, Cornelis H. van Werkhoven, Pieter Monsieurs, Christine Lammens, Annie Ducher, Maria J.G.T. Vehreschild, Herman Goossens, Jean de Gunzburg, Marc J.M. Bonten, Surbhi Malhotra-Kumar & the ANTICIPATE study group
Description
Summary:Antibiotic-induced modulation of the intestinal microbiota can lead to Clostridioides difficile infection (CDI), which is associated with considerable morbidity, mortality, and healthcare-costs globally. Therefore, identification of markers predictive of CDI could substantially contribute to guiding therapy and decreasing the infection burden. Here, we analyze the intestinal microbiota of hospitalized patients at increased CDI risk in a prospective, 90-day cohort-study before and after antibiotic treatment and at diarrhea onset. We show that patients developing CDI already exhibit significantly lower diversity before antibiotic treatment and a distinct microbiota enriched in Enterococcus and depleted of Ruminococcus, Blautia, Prevotella and Bifidobacterium compared to non-CDI patients. We find that antibiotic treatment-induced dysbiosis is class-specific with beta-lactams further increasing enterococcal abundance. Our findings, validated in an independent prospective patient cohort developing CDI, can be exploited to enrich for high-risk patients in prospective clinical trials, and to develop predictive microbiota-based diagnostics for management of patients at risk for CDI.
Item Description:The ANTICIPATE study group Annemarie Engbers, Ute Merle [und viele weitere Verfasser]
Gesehen am 09.06.2021
Physical Description:Online Resource
ISSN:2041-1723
DOI:10.1038/s41467-021-22302-0

Similar Items